Partners OxyPharma is currently working closely with the following companies:

Biology and Pharmacology

Aptuit
Aptuit is a leading pharmaceutical services organization headquartered in Greenwich, CT, USA. The company has extensive experience in preclinical studies and provides OxyPharma with services in toxicology, pharmacology and pharmacokinetics.

Quintiles Corp
Quintiles is a leading pharmaceutical services organization headquartered in North Carolina, USA. The company has extensive experience in clinical development and provides OxyPharma with services in pharmacokinetics (human).

Harlan Biotech Israel (HBI)
HBI is part of Harlan Industries, Inc., a provider of laboratory animals and pre-clinical laboratory services. HBI serves OxyPharma with pre-clinical evaluation with regard to efficacy screening of the company's candidate compounds.

Harlan Pharmacological & Biological Monitoring (HBPM)
Another subsidiary of Harlan Industries, HBPM is a biopharmaceutical company that provides a platform for pharmaceutical research and development through the PROBETM (Pharmacological Recording Of Bioactive Entities) program. HBPM assists OxyPharma in the analysis of chemical, pharmacological and pharmacokinetic properties of the company's candidate compounds.

MD Biosciences
MD Biosciences provides services and products for inflammatory drug discovery research as well as expertise and consultation on drug development projects. The company designs and executes in vivo pre-clinical protocols with a focus on Rheumatoid Arthritis, Multiple Sclerosis as well as other inflammatory diseases.

Pharm-Olam International
Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. Pharm-Olam International is currently carrying out OxyPharma's ongoing pivotal phase II clinical trial for Rabeximod for the treatment of RA.

Chemistry and Pharmacy

Medivir AB
Medivir is a Swedish biopharmaceutical company active in drug research and development. OxyPharma engages Medivir for Chemistry Manufacturing and Control (CMC) work.

Syntagon AB
A provider of synthetic organic chemistry services based in Sweden, Syntagon produces OxyPharma's compounds in accordance with current quality standards. Syntagon is inspected and approved by relevant authorities with respect to development and manufacturing of material for use in clinical trials.